As shown in Tables 1 and 2, in both tumor-bearing mouse models, the numbers of leukocytes, erythrocytes, reticulocytes and platelets as well as the percentage of CD34+ cells were elevated remarkably in combined therapy of SEP and 5-FU groups compared to 5-FU-treated group. This evidence concerns the gene CD34 and neoplasm.